LMAT - ルメイトレ・バスキュラ― (LeMaitre Vascular Inc.) ルメイトレ・バスキュラ―

 LMATのチャート


 LMATの企業情報

symbol LMAT
会社名 LeMaitre Vascular Inc (ルメイトレ・バスキュラ―)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 ルメイトレ・バスキュラー(LeMaitre Vascular Inc.)は末梢血管疾患の治療用の医療機器を提供する。同社は主に血管手術の分野で使用される医療機器およびインプラントを開発、製造、販売する。同社は末梢血管疾患産業セグメントの治療用の医療機器およびインプラントの設計、マーケティング、販売および技術サポートに従事している。同社の製品ラインには、バルボロトーム、バルーンカテーテル、頚動脈シャント、生物学的血管パッチ、放射線不透過性マーキングテープ、吻合クリップ、遠隔内膜切除装置、腹腔鏡胆嚢摘出装置、人工血管移植、生物学的血管移植および動脈摘出装置が含まれる。末梢血管装置のポートフォリオは、「Expandable LeMaitre Valvulotome」、「Pruitt F3 Carotid Shunt」、「VascuTape Radiopaque Tape」、「XenoSure biologic patch」など、心臓以外の動脈および静脈に使用されるブランド名の製品で構成される。   ルメイトレ・バスキュラ―は、米国の医療機器製造業者。おもに末梢血管疾患の治療、手術分野向けに医療装置やインプラントの開発、製造、販売を行う。弁膜切開刀、バル―ンカテ―テル、頸動脈バイパス、生物学的パッチ、放射線不透過性マ―キングテ―プ、吻合クリップ、遠隔膜切除装置、腹腔鏡下胆嚢摘出装置、血管移植片、電動静脈切除装置を提供する。   LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon.
本社所在地 63 Second Avenue Burlington MA 01803 USA
代表者氏名 George W. LeMaitre ジョージW・ルミターレ
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 781-221-2266
設立年月日 30621
市場名 NASDAQ National Market System
ipoyear 2006年
従業員数 423人
url www.lemaitre.com
nasdaq_url https://www.nasdaq.com/symbol/lmat
adr_tso
EBITDA EBITDA(百万ドル) 25.66000
終値(lastsale) 28.42
時価総額(marketcap) 553109642.12
時価総額 時価総額(百万ドル) 545.90870
売上高 売上高(百万ドル) 103.33200
企業価値(EV) 企業価値(EV)(百万ドル) ー
当期純利益 当期純利益(百万ドル) 20.40200
決算概要 決算概要 BRIEF: For the nine months ended 30 September 2018 LeMaitre Vascular Inc revenues increased 3% to $77.2M. Net income before extraordinary items increased 28% to $16.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Sales and Marketing - decrease of 30% to $13.6M (expense) Other General and Administrative decrease of 25% to $7.7M (expense).

 LMATのテクニカル分析


 LMATのニュース

   Lawrence J. Jasinski Sells 7,500 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock  2021/03/06 11:48:50 Watchlist News
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Director Lawrence J. Jasinski sold 7,500 shares of the firm’s stock in a transaction on Monday, March 1st. The stock was sold at an average price of $51.28, for a total transaction of $384,600.00. Following the completion of the transaction, the director now directly owns 10,833 shares of the company’s stock, […]
   Analyzing LeMaitre Vascular's Ex-Dividend Date  2021/03/05 10:11:00 Benzinga
LeMaitre Vascular (NASDAQ:LMAT) declared a dividend payable on March 25, 2021 to its shareholders as of February 23, 2021. It was also announced that …
   LeMaitre Vascular Will earnings report, end it's winning streak? Stock market Insights & financial analysis  2021/02/25 01:14:00 Stock Market Daily
LeMaitre Vascular announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Earnings Preview for LeMaitre Vascular  2021/02/24 10:27:00 Benzinga
LeMaitre Vascular (NASDAQ:LMAT) will be releasing its next round of earnings this Thursday, February 25. For all of the relevant information, here is your …
   The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO  2021/01/28 13:03:49 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 27) Abbott Laboratories (NYSE: ABT ) (reacted to fourth-quarter results) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) Atea Pharmaceuticals Inc (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) Aziyo Biologics Inc (NASDAQ: AZYO ) Cassava Sciences Inc (NASDAQ: SAVA ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Collplant Biotechnologies Ltd – ADR (NASDAQ: CLGN ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Frequency Therapeutics Inc (NASDAQ: FREQ ) (reacted to ratings upgrade by JPMorgan to Overweight) Fulgent Genetics Inc (NASDAQ: FLGT ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc. (NASDAQ: ILMN ) ImmuCell Corporation (NASDAQ: ICCC ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Kaleido Biosciences Inc (NASDAQ: KLDO ) LeMaitre Vascular Inc (NASDAQ: LMAT ) Ligand Pharmaceuticals Inc. (NASDAQ: LGND ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) Nantkwest Inc (NASDAQ: NK ) Penumbra Inc (NYSE: PEN ) Regulus Therapeutics Inc (NASDAQ: RGLS ) Rubius Therapeutics Inc (NASDAQ: RUBY ) Silence Therapeutics ADR Representing 3 Ord Shs (NASDAQ: SLN ) Summit Therapeutics Inc (NASDAQ: SMMT ) Supernus Pharmaceuticals Inc (NASDAQ: SUPN ) Tenax Therapeutics Inc (NASDAQ: TENX ) Vanda Pharmaceuticals Inc.
   The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO  2021/01/28 13:03:49 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 27) Abbott Laboratories (NYSE: ABT ) (reacted to fourth-quarter results) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) Atea Pharmaceuticals Inc (NASDAQ: AVIR ) AtriCure Inc. (NASDAQ: ATRC ) Aziyo Biologics Inc (NASDAQ: AZYO ) Cassava Sciences Inc (NASDAQ: SAVA ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Collplant Biotechnologies Ltd – ADR (NASDAQ: CLGN ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Frequency Therapeutics Inc (NASDAQ: FREQ ) (reacted to ratings upgrade by JPMorgan to Overweight) Fulgent Genetics Inc (NASDAQ: FLGT ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc. (NASDAQ: ILMN ) ImmuCell Corporation (NASDAQ: ICCC ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Kaleido Biosciences Inc (NASDAQ: KLDO ) LeMaitre Vascular Inc (NASDAQ: LMAT ) Ligand Pharmaceuticals Inc. (NASDAQ: LGND ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) Nantkwest Inc (NASDAQ: NK ) Penumbra Inc (NYSE: PEN ) Regulus Therapeutics Inc (NASDAQ: RGLS ) Rubius Therapeutics Inc (NASDAQ: RUBY ) Silence Therapeutics ADR Representing 3 Ord Shs (NASDAQ: SLN ) Summit Therapeutics Inc (NASDAQ: SMMT ) Supernus Pharmaceuticals Inc (NASDAQ: SUPN ) Tenax Therapeutics Inc (NASDAQ: TENX ) Vanda Pharmaceuticals Inc.
   The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement  2021/01/27 12:35:59 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 26) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) (reacted to new preclinical data showing its investigational asset ASLAN003 have the lowest potential for hepatotoxicity) BIOLASE Inc (NASDAQ: BIOL ) (reacted to its preliminary fourth-quarter results) BioNano Genomics Inc (NASDAQ: BNGO ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) Cassava Sciences Inc (NASDAQ: SAVA ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) DarioHealth Corp (NASDAQ: DRIO ) DermTech Inc (NASDAQ: DMTK ) Eli Lilly And Co (NYSE: LLY ) (reacted to positive data for its monoclonal antibody cocktail in treating COVID-19) ENDRA Life Sciences Inc (NASDAQ: NDRA ) ESSA Pharma Inc (NASDAQ: EPIX ) Evelo Biosciences Inc (NASDAQ: EVLO ) Evogene Ltd (NASDAQ: EVGN ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc.
   The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market  2021/01/26 13:07:39 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 25) Abbott Laboratories (NYSE: ABT ) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Antares Pharma Inc (NASDAQ: ATRS ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) argenx SE – ADR (NASDAQ: ARGX ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) (announced FDA approval for its oral lupus nephritis drug) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioNano Genomics Inc (NASDAQ: BNGO ) (reacted to positive sell-side commentary) Cassava Sciences Inc (NASDAQ: SAVA ) ChemoCentryx Inc (NASDAQ: CCXI ) Clearpoint Neuro Inc (NASDAQ: CLPT ) DarioHealth Corp (NASDAQ: DRIO ) DermTech Inc (NASDAQ: DMTK ) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (reacted to positive Phase 3 data for its COVID-19 antibody treatment bamlanivimab) Ekso Bionics Holdings Inc (NASDAQ: EKSO ) ENDRA Life Sciences Inc (NASDAQ: NDRA ) Evogene Ltd (NASDAQ: EVGN ) EXACT Sciences Corporation (NASDAQ: EXAS ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Halozyme Therapeutics, Inc.
   LeMaitre Vascular to Present at the Jefferies Virtual London Healthcare Conference - Stocks News Feed  2020/11/11 21:34:35 Stocks News Feed
BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that David Roberts, President, will present at Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020, at 12:25 PM ET. LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that… Read More »LeMaitre Vascular to Present at the Jefferies Virtual London Healthcare Conference
   LeMaitre Vascular to Present at Upcoming Investor Conferences - Stocks News Feed  2020/11/04 14:50:00 Stocks News Feed
Share this Stock Information BURLINGTON, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in November. David Roberts, President, is scheduled to present at the Stifel Virtual Healthcare Conference on Monday, November 16, 2020, at 8:00 AM ET. JJ Pellegrino, Chief Financial Officer, is scheduled to present at… Read More »LeMaitre Vascular to Present at Upcoming Investor Conferences
   LeMaitre Vascular to Present at the Jefferies Virtual London Healthcare Conference - Stocks News Feed  2020/11/11 21:34:35 Stocks News Feed
BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that David Roberts, President, will present at Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020, at 12:25 PM ET. LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that… Read More »LeMaitre Vascular to Present at the Jefferies Virtual London Healthcare Conference
   LeMaitre Vascular to Present at Upcoming Investor Conferences - Stocks News Feed  2020/11/04 14:50:00 Stocks News Feed
Share this Stock Information BURLINGTON, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in November. David Roberts, President, is scheduled to present at the Stifel Virtual Healthcare Conference on Monday, November 16, 2020, at 8:00 AM ET. JJ Pellegrino, Chief Financial Officer, is scheduled to present at… Read More »LeMaitre Vascular to Present at Upcoming Investor Conferences
   LeMaitre Vascular Does Earnings Surprise History Hold Any Clue for Stock market Insights & financial analysis  2020/10/29 18:45:00 Stock Market Daily
LeMaitre Vascular announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   LeMaitre Vascular, Inc. (NASDAQ:LMAT) Expected to Announce Earnings of $0.21 Per Share  2020/10/21 13:26:41 The Olympia Report
Equities research analysts expect LeMaitre Vascular, Inc. (NASDAQ:LMAT) to report $0.21 earnings per share for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for LeMaitre Vascular’s earnings, with the highest EPS estimate coming in at $0.22 and the lowest estimate coming in at $0.18. LeMaitre Vascular reported earnings per share […]
   More on LeMaitre Vascular's Q2 results (NASDAQ:LMAT)  2020/07/24 14:45:11 Seeking Alpha
LeMaitre Vascular's (LMAT +12.8%) Q2 sales declined 16% Y/Y to $24.9M with sales in the Americas (-15%) and Europe/Middle East/Africa (-21%) due to COVID-1

 関連キーワード  (先端医療機器_テクノロジ― 米国株 ルメイトレ・バスキュラ― LMAT LeMaitre Vascular Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)